A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Financial Summary
| Share Statistics | PFSA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.6 | $423.7 | 1% |
|
| Shares Out (Mil) | 0.1 | 41.5 | 1% |
|
| Institutional Ownership | 0.2% | 83.6% | 1% |
|
| Float (Mil) | 0.3 | 35.5 | 0% |
|
| Beta | 0.49 | 0.88 | 28% |
|
| Avg Daily Volume (000s) | 548 | 336 | 61% |
|
| Price Change (52-week) |
(99.9%) | 65.2% | 0% |
|
| Growth | PFSA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (18.8%) | (5.8%) | 21% |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PFSA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $119 | na |
|
| Net Income (TTM) (Mil) | ($43) | ($9) | 17% |
|
| EPS (TTM) | na | ($0.400) | na |
|
| Operating Cash Flow (TTM) (Mil) | ($20) | ($3) | 15% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $1 | 45% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $23 | 0% |
|
| Enterprise Value (Q1) (Mil) | $16 | $376 | 10% |
|
| Valuation | PFSA | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.87 | na |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | PFSA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 58.5% | na |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | na | (13.3%) | na |
|
| ROE | 56.8% | (13.3%) | 94% |
|
| Liabilities to Assets | na | 46.2% | na |
|
| F-Score | 1 | 4 | na |
|
Profusa, Inc. did not pass any screens on 9/3/2026.
